X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54015) 54015
Book Review (10331) 10331
Publication (5553) 5553
Book Chapter (649) 649
Conference Proceeding (644) 644
Dissertation (172) 172
Government Document (122) 122
Newsletter (77) 77
Reference (56) 56
Newspaper Article (29) 29
Book / eBook (16) 16
Magazine Article (15) 15
Trade Publication Article (8) 8
Data Set (7) 7
Web Resource (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40329) 40329
humans (31848) 31848
growth-factor receptor (25194) 25194
oncology (16708) 16708
animals (15603) 15603
female (13338) 13338
cancer (11261) 11261
male (10432) 10432
epidermal growth factor receptor (7888) 7888
expression (7558) 7558
middle aged (7539) 7539
mice (7344) 7344
epidermal growth factor receptors (7159) 7159
biochemistry & molecular biology (7158) 7158
signal transduction (6953) 6953
epidermal growth factor (6824) 6824
cell biology (6822) 6822
mutation (6724) 6724
aged (6504) 6504
adult (5905) 5905
cell line, tumor (5688) 5688
tumors (5537) 5537
research (5246) 5246
receptor, epidermal growth factor - metabolism (5209) 5209
phosphorylation (5113) 5113
chemotherapy (5059) 5059
proteins (4835) 4835
egfr (4544) 4544
analysis (4486) 4486
kinases (4311) 4311
gene expression (4267) 4267
immunohistochemistry (4267) 4267
prognosis (4264) 4264
receptor, epidermal growth factor - genetics (4172) 4172
apoptosis (4005) 4005
lung cancer (3922) 3922
activation (3915) 3915
care and treatment (3894) 3894
gefitinib (3889) 3889
genetic aspects (3852) 3852
metastasis (3572) 3572
article (3487) 3487
breast cancer (3438) 3438
antineoplastic agents - therapeutic use (3437) 3437
multidisciplinary sciences (3403) 3403
pharmacology & pharmacy (3350) 3350
health aspects (3326) 3326
cells (3221) 3221
medicine (3160) 3160
receptor, epidermal growth factor - antagonists & inhibitors (3074) 3074
aged, 80 and over (3045) 3045
survival (3042) 3042
research article (3031) 3031
therapy (3016) 3016
growth-factor-receptor (3008) 3008
tyrosine (2922) 2922
breast-cancer (2890) 2890
patients (2873) 2873
lung neoplasms - genetics (2800) 2800
cell proliferation (2774) 2774
pathology (2764) 2764
rats (2724) 2724
lung neoplasms - drug therapy (2673) 2673
antineoplastic agents - pharmacology (2622) 2622
cell lung-cancer (2579) 2579
growth factors (2531) 2531
physiological aspects (2442) 2442
lung neoplasms - pathology (2437) 2437
angiogenesis (2410) 2410
science (2362) 2362
erlotinib (2359) 2359
signal transduction - drug effects (2324) 2324
adenocarcinoma (2308) 2308
carcinoma (2296) 2296
development and progression (2293) 2293
treatment outcome (2271) 2271
tyrosine kinase inhibitor (2259) 2259
cells, cultured (2254) 2254
tyrosine kinase (2244) 2244
cancer therapies (2235) 2235
medicine, research & experimental (2213) 2213
cetuximab (2202) 2202
cell line (2178) 2178
vascular endothelial growth factor (2177) 2177
carcinoma, non-small-cell lung - drug therapy (2144) 2144
biology (2099) 2099
in-vivo (2068) 2068
medicine & public health (2065) 2065
gene expression regulation, neoplastic (2058) 2058
studies (2035) 2035
risk factors (2008) 2008
mutations (1990) 1990
in-vitro (1968) 1968
protein (1936) 1936
inhibition (1931) 1931
gene-expression (1926) 1926
gene (1924) 1924
cell proliferation - drug effects (1899) 1899
tyrosine kinase inhibitors (1892) 1892
ligands (1891) 1891
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51801) 51801
Chinese (1727) 1727
Japanese (1057) 1057
French (212) 212
German (163) 163
Korean (92) 92
Spanish (88) 88
Polish (36) 36
Russian (30) 30
Portuguese (19) 19
Turkish (13) 13
Czech (9) 9
Hungarian (8) 8
Italian (8) 8
Persian (4) 4
Lithuanian (3) 3
Dutch (2) 2
Swedish (2) 2
Croatian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BREAST CANCER RESEARCH, ISSN 1465-542X, 03/2015, Volume 17
Introduction Inflammatory breast cancer (IBC) is an aggressive type of breast cancer, characterized by very rapid progression, enlargement of the breast, skin... 
GROWTH-FACTOR RECEPTOR | METASTASIS | ONCOLOGY
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2017, Volume 18, Issue 11
Journal Article
Tumor Biology, ISSN 1010-4283, 10/2014, Volume 35, Issue 9, pp. 8653 - 8658
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s13277-014-2131-6 As the... 
Akt | Phosphatidylinositol 3-kinase | MMP9 | Glioblastoma,miRNA-181c | Epidermal growth factor receptor
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 09/2005, Volume 11, Issue 18, pp. 6414 - 6421
Purpose: To describe the Food and Drug Administration (FDA) review and approval of erlotinib (Tarceva, OSI Pharmaceuticals, Melville, NY) for treatment of... 
GROWTH-FACTOR RECEPTOR | GEFITINIB | ONCOLOGY | MUTATIONS
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 02/2019, Volume 14, Issue 2, pp. e25 - e27
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2018, Volume 24, Issue 24, pp. 6548 - 6555
Purpose: EGFR exon 20 insertions account for up to 10% of all EGFR mutations in lung adenocarcinomas, representing the third most common cluster of mutations.... 
GROWTH-FACTOR RECEPTOR | MUTANTS | AFATINIB | ONCOLOGY | CANCER | AUY922
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2004, Volume 22, Issue 5, pp. 777 - 784
Purpose The purpose of this study was to determine whether the addition of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa,... 
TRIAL | IRESSA | GROWTH-FACTOR RECEPTOR | EFFICACY | ONCOLOGY | TYROSINE KINASE | INHIBITOR | TUMORS | CHEMOTHERAPY
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 06/2019, Volume 46, Issue 6, pp. e221 - e222
Journal Article
DEVELOPMENTAL CELL, ISSN 1534-5807, 03/2013, Volume 24, Issue 5, pp. 459 - 471
EGFR and Hippo signaling pathways both control growth and, when dysregulated, contribute to tumorigenesis. We find that EGFR activates the Hippo pathway... 
GROWTH-FACTOR RECEPTOR | GENE | RAS | KINASE | FAT | CELL-PROLIFERATION | SIZE-CONTROL | DEVELOPMENTAL BIOLOGY | CANCER | DROSOPHILA | TUMOR-SUPPRESSOR PATHWAY | CELL BIOLOGY
Journal Article
ARTHRITIS & RHEUMATOLOGY, ISSN 2326-5191, 02/2018, Volume 70, Issue 2, pp. 230 - 241
Objective. To establish an unbiased, 3-dimensional (3-D) approach that quantifies subchondral bone plate (SBP) changes in mouse joints, and to investigate the... 
GROWTH-FACTOR RECEPTOR | ARTICULAR-CARTILAGE | DISEASE | MODEL | RHEUMATOLOGY | CROSSTALK
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 04/2013, Volume 19, Issue 8, pp. 2257 - 2264
Purpose: Test the hypothesis that in BRAF-mutated melanomas, clinical responses to selumetinib, a MEK inhibitor, will be restricted to tumors in which the... 
SURVIVAL | ACTIVATION | GROWTH-FACTOR-RECEPTOR | GENE | ONCOLOGY | RESISTANCE | BRAF | MUTATIONS | CANCER | BASAL
Journal Article
CANCER CELL, ISSN 1535-6108, 10/2013, Volume 24, Issue 4, pp. 438 - 449
EGFRvIll, a frequently occurring mutation in primary glioblastoma, results in a protein product that cannot bind ligand, but signals constitutively. Deducing... 
SURVIVAL | GROWTH-FACTOR RECEPTOR | CELLS | ACTIVATION | GENE | ONCOLOGY | HUMAN GLIOMAS | BLOCKADE | EXPRESSION | MULTIFORME | SIGNAL TRANSDUCER | CELL BIOLOGY
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2015, Volume 13, Issue 5, pp. 515 - 524
These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very... 
TYROSINE KINASE INHIBITORS | CLINICOPATHOLOGICAL CHARACTERISTICS | MOLECULAR-PATHOLOGY | ESMO CONSENSUS CONFERENCE | GROWTH-FACTOR-RECEPTOR | ALK GENE REARRANGEMENT | ONCOLOGY | ACQUIRED-RESISTANCE | EGFR MUTATION | TUMOR SPECIMENS | PERSONALIZED CANCER
Journal Article
07/2010
Aims: The involvement of various growth factors, growth factor receptors and proliferative markers in the molecular pathogenesis of astrocytic neoplasms are... 
proliferating cell nuclear antigen | glioblastoma | epidermal growth factor receptor | Astrocytoma
Web Resource
CANCER RESEARCH, ISSN 0008-5472, 03/2014, Volume 74, Issue 5, pp. 1541 - 1553
Great interest persists in useful prognostic and therapeutic targets in glioblastoma. In this study, we report the definition of miRNA ( miR)- 148a as a novel... 
SURVIVAL | INHIBITION | PROTEIN | GROWTH-FACTOR-RECEPTOR | ONCOLOGY | GENES | MET PATHWAY | DEATH | EXPRESSION | CANCER | TUMORS
Journal Article
Cancer Research, ISSN 0008-5472, 04/2010, Volume 70, Issue 8, pp. 3177 - 3188
NF-kappa B transcription factor is a critical regulator of the expression of genes involved in tumor formation and progression. Successful RNA interference... 
RNA INTERFERENCE | GROWTH-FACTOR RECEPTOR | NANOPARTICLES | THERAPY | ONCOLOGY | PLASMID DNA | LIGHT | OPTICAL-PROPERTIES | NANORODS | SIRNA | MAMMALIAN-CELLS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.